Distributed by



ID-Solutions, a French company, offers an innovative,  reliable and standardized tool for research and development in oncology diagnostics on circulating cell-free DNA from liquid biopsies and tumor DNA from solid biopsies. The IDENTIFY kits allow to detect multiplexed mutation panels using a fully validated, specific and sensitive digital PCR (dPCR) with the Stilla platform.

Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a ground-breaking and flexible Crystal Digital PCR (dPCR) solution : the naica® system

Through this partnership, the two French companies aim to offer standard operating procedures, diagnostic and theranostic tools with high sensitivity to meet the current clinical needs and requirements in oncology.